Kenneth R. Charette is a shareholder of the Firm’s Corporate, Business & Banking Group, as well as its Healthcare Group. He routinely assists clients with a wide range of business and corporate law matters, including, but not limited to: entity selection and formation, shareholder relations and corporate governance, mergers and acquisitions, raising capital, regulatory compliance, and general contract drafting and review.
In his healthcare law practice, Mr. Charette counsels hospitals, surgery centers, medical group practices, independent living facilities and other health care providers (as well as individual physicians) on transactions specific to the healthcare industry, such as the structuring of practice mergers/acquisitions or joint ventures, physician services agreements, billing and reimbursement matters, medical practice buy-ins/buy-outs and issues of regulatory compliance involving HIPAA’s patient privacy rules, the Stark Law, and the Anti-Kickback Statute.
He also advises clients on various types of international business transactions, such as licensing agreements, joint ventures, distributorships, import-export compliance and other forms of cross-border relationships.
For many private business owners, their ultimate “exit strategy” may involve the potential sale of their business to a third party. If you think that you may sell your business, then it is important that you begin to prepare for that possibility now. By making certain strategic decisions, you can make your company more attractive […]
by Kenneth R. Charette and Theresa M. DeAngelis, Summer Associate President Trump recently unveiled a new United States-Cuba policy that moves away from the more relaxed trade and travel policies introduced under the Obama Administration. Speaking in Miami’s Little Havana district, President Trump condemned the human rights violations of the Castro regime and later signed a six-page […]
by Kenneth R. Charette and Theresa M. DeAngelis, Summer Associate Many of our healthcare clients often inquire as to whether the Health Insurance Portability and Accountability Act of 1996 (HIPAA) permits the transfer or use of “de-identified” patient data. Such information has a variety of practical applications, including genetic research, comparative effectiveness studies, policy assessments, and […]